🇺🇸 FDA
Patent

US 12187779

Anti-human papillomavirus 16 E6 T cell receptors

granted A61KA61K38/00A61K40/11

Quick answer

US patent 12187779 (Anti-human papillomavirus 16 E6 T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K40/11, A61K40/32, A61K40/4272